Tresiba
Chemical Name | insulin degludec |
Dosage Form | Injection (subcutaneous; 300 units/3 mL, 600 units/3 mL, 1000 units/10 mL) |
Drug Class | Hormones |
System | Endocrine |
Company | Novo |
Approval Year | 2015 |
Indication
- To improve blood sugar (glucose) control in adults with diabetes mellitus.